Are Weight-Loss Drugs Also Longevity Drugs?

Two of the hottest trends in health — longevity medicine and weight loss drugs — are colliding. A theory that GLP-1 ...

What a Brooklyn bodega reveals about the craze for an experimental weight-loss drug

It isn't approved by the FDA, but we found an experimental weight-loss drug called retatrutide for sale at a local ...
Labiotech.eu

The hidden innovation system behind drug repurposing

Delve into the hidden innovation system of drug repurposing. When patents expire and commercial value fades, a new wave of ...
Daily Maverick

Drugs like Ozempic show promise for more than weight loss. But what’s the science?

Emerging research reveals GLP-1 drugs like Ozempic may combat diseases beyond obesity, including cancer and addiction, though ...

Women are hacking hormonal health with allergy drugs and antacids

Can an antihistamine a day keep the hot flashes away?
MedPage Today on MSN

Loss of Payment Assistance for AMD Drugs Strains Patients and Ophthalmologists

Pervasive "unsustainable" clinical practices amid cat-and-mouse game with funding availabi ...

From Caffeine To 'Healthy' Labeling, FDA Sets Year-End Agenda For US Food Supply

For example, the FDA plans to draft guidance on action levels for cadmium and inorganic arsenic in food products meant for ...
Morning Overview on MSN

A huge Lancet study says statins don’t cause most of the side effects on their labels

Millions of people who take statins for heart disease prevention have been warned about dozens of possible side effects on ...
Futurism on MSNOpinion

Cops Caught Using AI to Edit Picture of Pathetic Drug Bust

"I like being lied to by the police, it's good for building trust!" The post Cops Caught Using AI to Edit Picture of Pathetic ...

'They're not alone in being confused': Nearly 1 in 3 Americans struggle with prescription labels — and mistakes can cost them hundreds in extra bills

A prescription label isn't always as clear as it looks, and when instructions get misread or don't fully stick, it can lead to more than just a small mix-up — sometimes it means extra doctor visits, ...

FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Infants Down to 3 Months

FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of February 23, 2027Application supported by positive results from Phase ...